Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Outstanding for 16 consecutive years, with $24.4 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.01% to $24.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.4 million through Dec 2025, up 1.01% year-over-year, with the annual reading at $24.4 million for FY2025, 1.01% up from the prior year.
  • Shares Outstanding for Q4 2025 was $24.4 million at Lemaitre Vascular, roughly flat from $24.3 million in the prior quarter.
  • The five-year high for Shares Outstanding was $24.4 million in Q4 2025, with the low at $1.5 million in Q1 2021.
  • Average Shares Outstanding over 5 years is $21.6 million, with a median of $23.8 million recorded in 2023.
  • The sharpest move saw Shares Outstanding tumbled 93.33% in 2023, then soared 1430.99% in 2024.
  • Over 5 years, Shares Outstanding stood at $23.5 million in 2021, then grew by 0.76% to $23.7 million in 2022, then grew by 1.08% to $23.9 million in 2023, then rose by 1.01% to $24.2 million in 2024, then grew by 1.01% to $24.4 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $24.4 million, $24.3 million, and $24.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.